Revive Therapeutics LtdOTCQB:RVVTFView on Canadian Exchange
- LAST PRICE0.0083
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.0021/ 100
- Ask / Lots0.0158/ 100
- Open / Previous Close--- / 0.0083
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | RVVTF |
|---|---|---|
| 09:32 ET | 1000 | 0.0071 |
| 10:02 ET | 1000 | 0.0076 |
| 10:51 ET | 10000 | 0.0078 |
| 11:38 ET | 83700 | 0.0085 |
| 11:43 ET | 7000 | 0.0083 |
| 11:45 ET | 900 | 0.00825 |
| 12:03 ET | 4300 | 0.00825 |
| 12:06 ET | 10000 | 0.008 |
| 12:19 ET | 500 | 0.008 |
| 12:32 ET | 100 | 0.00835 |
| 01:04 ET | 6000 | 0.0083 |
| 01:06 ET | 1000 | 0.008 |
| 01:15 ET | 1000 | 0.008 |
| 02:21 ET | 559 | 0.00825 |
| 02:34 ET | 9090 | 0.00825 |
| 03:08 ET | 1815 | 0.00825 |
Nov 12, 2024
Revive Therapeutics Announces Publication Demonstrating Novel Therapeutic Approach of Psilocybin in Stroke, from 7:45AM ET on Tuesday Nov 12, 2024 by Dow Jones
7:45AM ET on Tuesday Nov 12, 2024 by Dow Jones
Oct 31, 2024
Revive Therapeutics Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure, from 7:30AM ET on Thursday Oct 31, 2024 by Dow Jones
7:30AM ET on Thursday Oct 31, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Revive Therapeutics Ltd | 4.2M | --- | --- |
Company Information
Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. It also advancing the development of Psilocybin-based therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).
Contact Information
- Headquarters
- 82 Richmond Street EastTORONTO, ON, Canada M5C 1P1
- Phone
- 905-605-5535
- Fax
- 905-605-5535
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.2M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 418.6M |
Revive Therapeutics Ltd does not pay a dividend. | |
Beta | -0.03 |
EPS | $-0.01 |
Book Value | $0.02 |
P/E Ratio | --- |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
